The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-1-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-ylsulfonyl)pyrrolidine-2-carboxylic acid ID: ALA4171143
PubChem CID: 984803
Max Phase: Preclinical
Molecular Formula: C18H18N2O5S
Molecular Weight: 374.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCN1C(=O)c2cccc3c(S(=O)(=O)N4CCC[C@@H]4C(=O)O)ccc1c23
Standard InChI: InChI=1S/C18H18N2O5S/c1-2-19-13-8-9-15(11-5-3-6-12(16(11)13)17(19)21)26(24,25)20-10-4-7-14(20)18(22)23/h3,5-6,8-9,14H,2,4,7,10H2,1H3,(H,22,23)/t14-/m1/s1
Standard InChI Key: GWXPEKYEANOENV-CQSZACIVSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
6.4509 -20.2152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4550 -21.0324 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.1606 -20.6202 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4160 -23.1379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2345 -23.1364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6389 -22.4321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2315 -21.7323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6409 -21.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2377 -20.3248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4210 -20.3238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0153 -21.0253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0098 -22.4311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4154 -21.7282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2175 -21.3398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2159 -22.1758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5551 -22.6565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5424 -20.8793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8631 -21.7452 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5748 -20.0644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5309 -22.4919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1393 -23.0437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8522 -22.6356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6842 -21.8316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2321 -21.2253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0311 -21.3967 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9810 -20.4477 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
12 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
13 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 13 2 0
12 13 1 0
14 15 1 0
15 12 1 0
14 11 1 0
15 16 2 0
14 17 1 0
8 2 1 0
2 18 1 0
17 19 1 0
18 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 18 1 0
23 24 1 1
24 25 2 0
24 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.42Molecular Weight (Monoisotopic): 374.0936AlogP: 2.06#Rotatable Bonds: 4Polar Surface Area: 94.99Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.02CX Basic pKa: ┄CX LogP: 1.45CX LogD: -2.02Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.88Np Likeness Score: -1.39
References 1. Feng Y, Xiao S, Chen Y, Jiang H, Liu N, Luo C, Chen S, Chen H.. (2018) Design, synthesis and biological evaluation of benzo[cd]indol-2(1H)-ones derivatives as BRD4 inhibitors., 152 [PMID:29730189 ] [10.1016/j.ejmech.2018.04.048 ]